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Hematopoietic stem and progenitor cells (HSPC) are essential for sustained production of red and 
white blood cells. Although HSPC transplantation has a wide variety of clinical applications, HSPCs 
are difficult to expand ex vivo, highlighting the need to understand their basic biology. Protein 
methyltransferases are known to play key roles in regulating gene expression, but their part in 
regulating chromatin structure had not been clearly defined. G9a and GLP are two related protein 
methyltransferases that are required for de novo methylation of histone H3 on lysine 9, (H3K9me2), 
a histone mark associated with transcriptional repression. In a new study published inEpigenetics 
and Chromatin, Dr. Xiaoji Chen, a former graduate student in the lab of Dr. Patrick Paddison 
(Human Biology Division), along with their collaborators, addressed the role of G9a /GLP in 
controlling chromatin structure in HSPCs. 
The authors had previously found that H3K9me2 marks are largely absent in HSPCs and are formed 
de novo in more committed HSPCs. In committed HSPCs, G9a/GLP activity nucleates H3K9me2 
marks at CpG islands (cytosine nucleotide followed by a guanine; CGIs), as well as at other genomic 
sites, which then spread to form domains known as chromatin territories. They had further 
demonstrated that treatment of HSPCs with a small molecule inhibitor of G9a/GLP 
methyltransferase activity (UNC0638), resulted in genome-wide loss of H3K9me2 and improved 
retention of stem cell properties by HSPCs (Chen et al., 2012). 
To address the role of G9a/GLP-dependent patterning of H3K9me2 on chromatin structure, the 
authors profiled chromatin accessibility of committed HSPCs treated with UNC0638 using a 
technique called FAIRE-seq (Formaldehyde-Assisted Isolation of Regulatory Elements), which 
enables detection of nucleosome-depleted regions of the genome. Integration of the FAIRE-seq data 
with ChIP-seq (Chromatin immunoprecipitation followed by high throughput sequencing) for 
H3K9me2 and DNA methylation data from the same cells revealed that loss of H3K9me2 caused by 
UNC0638 treatment led to an increase in chromatin accessibility. Importantly, increased chromatin 
accessibility was largely restricted to sites of H3K9me2 nucleation. "This paper helps cross validate 
our work on histone H3 methylation patterning during human blood lineage development, by 
showing that these marks have an impact on chromatin structure," said Dr. Paddison. 
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Previous results had demonstrated that about half of the H3K9me2 sites coincided with CGIs, but 
the sequence basis for the other half had remained unexplained. Further examination of non-CGI 
sites revealed that they had similar GC and CpG content to CGIs, yet did not meet the criteria for 
CGI classification. Next, the authors compared FAIRE-seq read counts at promoter-associated CGIs 
or at "orphan" CGIs, which have unknown functions. This analysis revealed that both sets of CGIs 
displayed an increase in chromatin accessibility in response to UNC0638 treatment. Finally, the 
authors investigated the role of DNA methylation in the response to UNC0638 treatment and found 
that the biggest changes in chromatin accessibility occurred at unmethylated CGIs, which have low 
rates of cytosine-to-thymine deamination. 
In summary, this study showed that H3K9me2 patterning regulates chromatin structure at promoter 
and "orphan" CGIs, promoting "closed" chromatin states. "Although we still haven't deciphered their 
exact biological significance, the work sheds light on another feature of our genome: CpG islands. In 
this case, we find that CpG islands are sites where these histone methylation marks are initially laid 
down, which is really unexpected and enables us to assign a biological function to thousands of 
'orphan' sites that previously did not have a function. Something interesting is afoot," explained Dr. 
Paddison. 
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Previous work had shown that histone H3 lysine 9 
dimethylation (H3K9me2) is absent or low in human adult 
hematopoietic stem cells and is progressively patterned 
during differentiation across most of the coding regions of 
the genome. Both previous and current work highlight the 
fact that these patterning events are nucleated at CpG 
islands by the G9a and GLP protein methyltransferases. 
Importantly, this work establishes a function for orphan 
CpG islands (previously unknown). 
 
